載入...
Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
Currently, a marked number of clinical trials on cancer treatment have revealed the success of immunomodulatory therapies based on immune checkpoint inhibitors that activate tumor-specific T cells. However, the therapeutic efficacy of cancer immunotherapies is only restricted to a small fraction of...
Na minha lista:
| 發表在: | Front Immunol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5829092/ https://ncbi.nlm.nih.gov/pubmed/29527212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00353 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|